Kaitlin Christine

Kaitlin Christine is the CEO and founder of Gabbi Inc., a FemTech company focused on reducing late-stage breast cancer through advanced risk assessment and early detection solutions. With more than a decade of experience in women's health, Christine began her career as the youngest hire at Myriad Genetics, a leading genetic testing company, and later contributed to scaling Worth eCommerce to acquisition as its first full-time hire. At Gabbi, Christine has led fundraising efforts, built a diverse expert team, and established healthcare partnerships, emphasizing innovation in early cancer detection.

Christine’s background as a breast cancer survivor and ovarian cancer previvor has positioned her as a national speaker at conferences such as TEDx, HLTH, HIMSS, and HITLAB. She has received recognition including Oregon Entrepreneur of the Year, Inc’s Top Female Founders, Rock Health’s Top Digital Health Disruptor, Fierce Healthcare’s Top Innovator, and acknowledgment by the White House for her contributions to early detection. Christine also serves on the leadership board of the United States Breast Cancer Early Detection Coalition, supporting advancements in the field.

Christine’s public speaking combines personal experience with practical insights, encouraging audiences to advocate for themselves and support systemic change in healthcare. Her experience overcoming personal and family health challenges, along with her business expertise and commitment to women’s health, highlights her role as a leader and communicator in the health technology sector.